1. Home
  2. SLXN vs CTHR Comparison

SLXN vs CTHR Comparison

Compare SLXN & CTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLXN
  • CTHR
  • Stock Information
  • Founded
  • SLXN 2008
  • CTHR 1995
  • Country
  • SLXN Israel
  • CTHR United States
  • Employees
  • SLXN N/A
  • CTHR N/A
  • Industry
  • SLXN
  • CTHR Consumer Specialties
  • Sector
  • SLXN
  • CTHR Consumer Discretionary
  • Exchange
  • SLXN NYSE
  • CTHR Nasdaq
  • Market Cap
  • SLXN 4.3M
  • CTHR 4.1M
  • IPO Year
  • SLXN N/A
  • CTHR 1997
  • Fundamental
  • Price
  • SLXN $0.84
  • CTHR $1.41
  • Analyst Decision
  • SLXN Strong Buy
  • CTHR
  • Analyst Count
  • SLXN 1
  • CTHR 0
  • Target Price
  • SLXN $9.00
  • CTHR N/A
  • AVG Volume (30 Days)
  • SLXN 31.1M
  • CTHR 10.5K
  • Earning Date
  • SLXN 03-04-2025
  • CTHR 03-04-2025
  • Dividend Yield
  • SLXN N/A
  • CTHR N/A
  • EPS Growth
  • SLXN N/A
  • CTHR N/A
  • EPS
  • SLXN N/A
  • CTHR N/A
  • Revenue
  • SLXN N/A
  • CTHR $23,684,860.00
  • Revenue This Year
  • SLXN N/A
  • CTHR $31.82
  • Revenue Next Year
  • SLXN N/A
  • CTHR N/A
  • P/E Ratio
  • SLXN N/A
  • CTHR N/A
  • Revenue Growth
  • SLXN N/A
  • CTHR N/A
  • 52 Week Low
  • SLXN $0.21
  • CTHR $1.16
  • 52 Week High
  • SLXN $13.56
  • CTHR $4.30
  • Technical
  • Relative Strength Index (RSI)
  • SLXN N/A
  • CTHR 46.53
  • Support Level
  • SLXN N/A
  • CTHR $1.28
  • Resistance Level
  • SLXN N/A
  • CTHR $1.40
  • Average True Range (ATR)
  • SLXN 0.00
  • CTHR 0.07
  • MACD
  • SLXN 0.00
  • CTHR -0.01
  • Stochastic Oscillator
  • SLXN 0.00
  • CTHR 54.17

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.

About CTHR Charles & Colvard Ltd

Charles & Colvard Ltd manufactures, markets, and distributes finished jewellery which also includes moissanite gemstone in the jewellery market. The company sells jewels through two operating segments namely Online Channels segment and Traditional segment. It generates maximum revenue from the Online Channels segment. Online Channels segment which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, third-party online marketplaces, drop-ship retail, and other pure-play, exclusively e-commerce outlets.

Share on Social Networks: